Cicor Technologies Ltd., together with its subsidiaries, develops, and manufactures electronic components, devices, and systems internationally. The company operates in two segments: Electronic Manufacturing Services (EMS) and Advanced Substrates (AS). It offers engineering services, such as test engineering, product, test development, and process engineering services; electronic manufacturing services, including printed circuit board (PCB) assembly, cable assembly, box building, and microelectronic assembly; precision plastics, such as tool design and fabrication, plastic injection molding, and 3D-MID technology; hybrid circuits that include thin-film and thick-film substrates; PCBs comprises flexible, rigid-flexible, rigid, and DenciTec PCBs; AC/DC and DC/DC power solutions; and printed electronics. The company also provides porototyping shops; and outsourcing solutions for the development and manufacture of electronic assemblies, as well as complete devices and systems. It serves industrial, health care, aerospace and defense, wearables, and building technologies markets. The company was formerly known as Cicorel Holding SA and changed its name to Cicor Technologies Ltd. in 2005. Cicor Technologies Ltd. was founded in 1966 and is based in Bronschhofen, Switzerland.…
Vallourec shares slide over 12% on weak Q4 core earnings outlook
Cicor Technologies (SWX: CICN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Electronic Components industry, part of the Technology sector, and reports about 4,521 employees.
The shares were at 134.20 CHF on 20 November 2026, down 24.0% over 52 weeks. Its 52-week range is 110.20 CHF to 192.50 CHF: the price is 30.3% below the high and 21.8% above the low.
At a market capitalisation of 585.57M CHF, it trades at 41.3 times trailing earnings and 13.4 times forward earnings. The median trailing P/E of its 19 largest Electronic Components peers is 23.7, a premium of 74% for CICN.
Cicor Technologies reports return on equity of 11.2%, an operating margin of 4.2% and revenue up 19.0% year over year.
Its debt exceeds its cash by 82.60M CHF, a debt-to-equity ratio of 1.06. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 9 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 173.11 CHF is 29.0% above the current price. The next earnings report is expected on 4 March 2027.